Helping Protect Patients and Staff on the COVID front lines
Illuvia® HEPA – Ultraviolet Air recirculation system (HUAIRS®) Designed for
- Diagnostic, Treatment and Transition areas
- Aerosol-generating procedures
- ICU’s, ED’s L&D
Call Now to learn more about our solution
the Illuvia® HUAIRS +1 888 978 7087
Call Now to learn more about our solution the Illuvia® HUAIRS
+1 888 978 7087
Elevated bacterial content in OR air causes increased surgical site infection rates.
Prospective randomized multicenter study results shows that joint replacement procedures performed in rooms with over 50 CFU/m³ airborne bacterial colony forming units per cubic meter were 2.6 times as likely to have postoperative SSI than those done in cleaner air with 20 CFU/m³.
– OM LIDWELL, JOURNAL OF HOSPITAL INFECTION
Keeping Hospitals Safe
Illuvia® HEPA – Ultraviolet Air recirculation system (HUAIRS®)
Hospital air is contaminated with airborne microbes which can cause dangerous surgical site infections. Learn how the Illuvia® system is keeping patients safe.
Call Now to learn more about our solution
the Illuvia® HUAIRS +1 888 978 7087
News and Events
Aerobiotix welcomes Aerobiovac, the Exclusive Distributor for Canada
Aerobiotix is pleased to partner with Aerobiovac to bring our leading air disinfection technology to Canada.
Aerobiotix Announces FDA 510(k) Clearance of Medical Ultraviolet Air Filtration System
MIAMISBURG, Ohio--(BUSINESS WIRE)--Aerobiotix, Inc., a leading manufacturer of air treatment devices for hospitals and healthcare, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the Aerocure-MD medical air purification system.
Aerobiotix, Inc. Announces Strategic Partnership with APIC
Aerobiotix today announced a strategic partnership with the Association for Professionals in Infection Control and Epidemiology (APIC)
WHIO 7 Report: Improved Airborne Environments with the Illuvia HUAIRS
DAYTON, Ohio (WHIO7): Aerobiotix profiled in this report from WHIO 7 in Dayton, Ohio.
The Results are in… The Illuvia® HUAIRS is the ONLY technology tested to remove airborne SARS-CoV-2
Evidence shows that SARS-CoV-2 is airborne.1,2 Aerobiotix ILLUVIA® air disinfection systems are the only technology proven to remove airborne SARS-CoV-2 in direct independent testing.
Montgomery Co. Common Pleas Court acquires air cleaning systems
DAYTON, Ohio (WKEF/WRGT) -- Ultraviolet air cleaning systems are right now being used in the Montgomery County Common Pleas Court. This as some judges prepare to host their first jury trials since the COVID-19 pandemic began.
Aerobiotix Partners with Surgery Center of Fort Lauderdale Clean Air Initiative
Their dedication to patient safety and air quality goes above and beyond.
Aerobiotix joins Clean Hospitals, a Healthcare Environmental Hygiene Network
A coalition of international stakeholders, Academia, Governmental Bodies, NGO’s, hospitals and industry.
Aerobiotix partners with Battelle to perform SARS-CoV-2 bioaerosol elimination testing
This critical work will utilize Battelle’s biosafety facility in Columbus, Ohio using custom-designed aerosolization and sampling chambers.
Minnesota Orthopedic Center using Illuvia HUAIRS® to kill viruses in operating rooms as elective procedures resume.
“It’s a special device that turns the air over even more frequently in the operating room,” O’Neill explained. “It’s actually got ultraviolet light associated with it and so it kills any virus that may be in the OR.”
Illuvia Installed Alexandrovska University Hospital, Bulgaria
Thanks to our partners in Bulgaria - Vega Medical and the Alexandrovska University Hospital for the installation of the first ILLUVIA 500 in the Second Surgery Department in the hospital.
Dr. Kirschman Letter on Coronavirus
We have received many inquiries regarding the use of Aerobiotix, Inc. systems in the Coronavirus epidemic, so we are releasing the following letter describing the scientific basis to support use within established guidelines.
News and Events
Aerobiotix welcomes Aerobiovac, the Exclusive Distributor for Canada
Aerobiotix is pleased to partner with Aerobiovac to bring our leading air disinfection technology to Canada.
Aerobiotix Announces FDA 510(k) Clearance of Medical Ultraviolet Air Filtration System
MIAMISBURG, Ohio--(BUSINESS WIRE)--Aerobiotix, Inc., a leading manufacturer of air treatment devices for hospitals and healthcare, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the Aerocure-MD medical air purification system.
Aerobiotix, Inc. Announces Strategic Partnership with APIC
Aerobiotix today announced a strategic partnership with the Association for Professionals in Infection Control and Epidemiology (APIC)
WHIO 7 Report: Improved Airborne Environments with the Illuvia HUAIRS
DAYTON, Ohio (WHIO7): Aerobiotix profiled in this report from WHIO 7 in Dayton, Ohio.
The Results are in… The Illuvia® HUAIRS is the ONLY technology tested to remove airborne SARS-CoV-2
Evidence shows that SARS-CoV-2 is airborne.1,2 Aerobiotix ILLUVIA® air disinfection systems are the only technology proven to remove airborne SARS-CoV-2 in direct independent testing.
Montgomery Co. Common Pleas Court acquires air cleaning systems
DAYTON, Ohio (WKEF/WRGT) -- Ultraviolet air cleaning systems are right now being used in the Montgomery County Common Pleas Court. This as some judges prepare to host their first jury trials since the COVID-19 pandemic began.
Aerobiotix Partners with Surgery Center of Fort Lauderdale Clean Air Initiative
Their dedication to patient safety and air quality goes above and beyond.
Aerobiotix joins Clean Hospitals, a Healthcare Environmental Hygiene Network
A coalition of international stakeholders, Academia, Governmental Bodies, NGO’s, hospitals and industry.
Aerobiotix partners with Battelle to perform SARS-CoV-2 bioaerosol elimination testing
This critical work will utilize Battelle’s biosafety facility in Columbus, Ohio using custom-designed aerosolization and sampling chambers.
Minnesota Orthopedic Center using Illuvia HUAIRS® to kill viruses in operating rooms as elective procedures resume.
“It’s a special device that turns the air over even more frequently in the operating room,” O’Neill explained. “It’s actually got ultraviolet light associated with it and so it kills any virus that may be in the OR.”
Illuvia Installed Alexandrovska University Hospital, Bulgaria
Thanks to our partners in Bulgaria - Vega Medical and the Alexandrovska University Hospital for the installation of the first ILLUVIA 500 in the Second Surgery Department in the hospital.
Dr. Kirschman Letter on Coronavirus
We have received many inquiries regarding the use of Aerobiotix, Inc. systems in the Coronavirus epidemic, so we are releasing the following letter describing the scientific basis to support use within established guidelines.
CLEANER AIR MEANS BETTER HEALTHCARE
Surgical site infections (SSIs) continue to constitute a significant fraction of hospital-acquired infections contributing to morbidity and mortality to healthcare systems globally. There are approximately 290,000 incidences of SSIs in the USA alone each year, translating into economic loss of $8.36 billion. A significant portion of SSIs have been proven to be airborne in origin and correlate with increased bacterial air content.
Call Now to learn more about our solution
the Illuvia® HUAIRS +1 888 978 7087
The International Consensus Meeting on Musculoskeletal Infection is the definitive meeting of global leaders in orthopedic infection. Chaired by Dr. Javad Parvizi, the latest meeting was July 2018 in Philadelphia and attended by over 400 delegates.
By a 94% consensus, these leaders stated that: “the amount of airborne contamination in the active operating room should be minimized to prevent surgical site infection/PJI.” Only Illuvia HUAIRS is designed to reduce the possibility of surgical infections by decontaminating intraoperative air with a combination of advanced ultraviolet and HEPA technologies.
